article · Neurology

Comprehensive Review of Hypogammaglobulinemia and Infection Rates in MS Patients Treated with Anti-CD20 Antibodies (P8-1.007)

Anas Elgenidy
Omar Alomarı
Mohammed Al‐mahdi Al‐kurdi
Mohammed M. Ghoneim
Ahmed Anan
Lobna A. Mohamed
Hazem Khaled Hassaan
Ahmed Wagdy Fathy
Nagham Nader Abdelhalim

2025Alexandria University

Abstract

To investigate the relationship between anti-CD20 treatments in Multiple Sclerosis (MS), serum immunoglobulin G (IgG) levels, and the risk of hypogammaglobulinemia and infections, aiming to inform treatment strategies to prevent severe infections.

Research topics

Immunodeficiency and Autoimmune Disorders
Chronic Lymphocytic Leukemia Research
Blood groups and transfusion

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1212/wnl.0000000000211418

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.